Altimmune Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Aug 23 | BuyUS$863 | David Drutz | Individual | 300 | US$2.88 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 515,367 | 0.727% |
General Public | 25,852,833 | 36.5% |
Institutions | 44,533,991 | 62.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,649,270 | US$57.1m | 753% | no data | |||
4,042,226 | US$26.7m | -0.06% | no data | |||
3,128,728 | US$20.6m | -12.4% | no data | |||
2,750,000 | US$18.1m | 0% | 2.34% | |||
1,709,304 | US$11.3m | -59.1% | no data | |||
1,619,500 | US$10.7m | 292% | no data | |||
1,590,150 | US$10.5m | 813% | 0.01% | |||
1,236,798 | US$8.2m | 3.63% | no data | |||
1,123,451 | US$7.4m | 19.5% | 0.01% | |||
993,516 | US$6.6m | 204% | 0.03% | |||
911,131 | US$6.0m | -47.1% | no data | |||
887,255 | US$5.9m | 0% | 0.45% | |||
882,628 | US$5.8m | 0% | 0.02% | |||
825,800 | US$5.5m | 0% | 0.31% | |||
742,913 | US$4.9m | 9,700% | no data | |||
713,326 | US$4.7m | 56.6% | no data | |||
567,599 | US$3.7m | -6.79% | no data | |||
567,219 | US$3.7m | 184% | 3.42% | |||
508,201 | US$3.4m | 772% | no data | |||
495,261 | US$3.3m | 1,930% | no data | |||
493,968 | US$3.3m | 4.25% | no data | |||
470,000 | US$3.1m | 1,280% | 0.02% | |||
432,666 | US$2.9m | 0.08% | 0.01% | |||
358,513 | US$2.4m | 0% | 0.18% | |||
354,350 | US$2.3m | 22.3% | no data |